VHCP Management’s Ocera Therapeutics OCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCRX
SM
ECM
VHCP Management's OCRX Position: Q4 2016 in Review
VHCP Management increased its Ocera Therapeutics (OCRX) stake by 6.5% in Q4 2016, buying an estimated $130K and bringing the position to 912,050 shares worth $1.92M. The position accounts for 2.06% of the portfolio, ranked #11.
VHCP Management first reported a position in OCRX in Q4 2013 and has held it in 13 quarters since. The position peaked at $9.14M in Q4 2013. 36 funds tracked by Wall St. Rank hold OCRX as of Q4 2016.
- VHCP Management held 912,050 shares of Ocera Therapeutics worth $1.92M as of Q4 2016.
- VHCP Management bought 55,500 Ocera Therapeutics shares in Q4 2016, an estimated $130K.
- Ocera Therapeutics made up 2.06% of VHCP Management's portfolio in Q4 2016, its #11 holding.
- VHCP Management first reported a position in Ocera Therapeutics in Q4 2013 and has held it in 13 quarters since.
- VHCP Management's Ocera Therapeutics position peaked at $9.14M in Q4 2013.
- 36 funds tracked by Wall St. Rank held Ocera Therapeutics as of Q4 2016.
Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.